Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Inhibio AS
AS
Active
Org 911637979
Tollbugata 24, 0157
Oslo
Forskning og utviklingsarbeid innen bioteknologi
·
NACE 72110
Est. 2013 · 13 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Forskning og utviklingsarbeid innen bioteknologi
/
Inhibio AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
5M
4M
2M
1M
0M
2017: 2M
2M
2017
2018: 4M (+100% vs 2017)
4M
+100%
2018
2019: 2M (-50% vs 2018)
2M
-50%
2019
2020: 3M (+50% vs 2019)
3M
+50%
2020
2021: 3M (0% vs 2020)
3M
0%
2021
EBITDA
NOK millions
0M
-1M
-2M
-4M
-5M
2017: -4M
-4M
2017
2018: -1M (+75% vs 2017)
-1M
+75%
2018
2019: -1M (0% vs 2018)
-1M
0%
2019
2020: -1M (0% vs 2019)
-1M
0%
2020
2021: -2M (-100% vs 2020)
-2M
-100%
2021
Income statement
NOK thousands
Item
2021
2020
2019
2018
2017
Revenue
3 485
3 104
2 407
3 559
2 227
Staff expenses
−1 420
−1 150
−672
−672
−545
EBITDA
−1 729
−887
−639
−922
−4 005
Depreciation & amort.
−16
−3
−0
−0
−0
EBIT
−1 745
−890
−639
−922
−4 005
Net financials
−147
−191
−349
−260
−139
Profit before tax
−1 891
−1 081
−989
−1 182
−4 144
Tax
−0
−0
−0
−0
−0
Net profit
−1 891
−1 081
−989
−1 182
−4 144
Balance sheet
NOK thousands
Item
2021
2020
2019
2018
2017
Total assets
4 774
3 224
1 677
2 839
528
Equity
−1 745
−974
−7 144
−6 155
−4 973
Long-term debt
2 731
350
7 401
6 172
3 062
Short-term debt
3 788
3 848
1 420
2 822
2 440
Total debt
6 519
4 198
8 821
8 993
5 501
Financial ratios
5-year trend
EBITDA margin
−49,6 %
This company
15,8 %
Market median
This company
Market median
414% below market
2017
2021
Equity ratio
−36,5 %
This company
38,2 %
Market median
This company
Market median
196% below market
2017
2021
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2017
2021
Net profit margin
−54,3 %
This company
8,1 %
Market median
This company
Market median
770% below market
2017
2021
Asset turnover
0,73×
This company
1,12×
Market median
This company
Market median
35% below market
2017
2021
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2017
2021
Annual reports & filings
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
View
PDF
More on Inhibio AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
